These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8797862)

  • 61. Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not c-raf-1 protein.
    Warenius HM; Seabra LA; Maw P
    Int J Cancer; 1996 Jul; 67(2):224-31. PubMed ID: 8760592
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers.
    Hosokawa Y; Gadd M; Smith AP; Koerner FC; Schmidt EV; Arnold A
    Cancer Lett; 1997 Feb; 113(1-2):123-30. PubMed ID: 9065811
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
    Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
    Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient.
    Husdal A; Bukholm G; Bukholm IR
    Cell Oncol; 2006; 28(3):107-16. PubMed ID: 16823179
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.
    Gansauge S; Gansauge F; Ramadani M; Stobbe H; Rau B; Harada N; Beger HG
    Cancer Res; 1997 May; 57(9):1634-7. PubMed ID: 9134998
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
    Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
    Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amplification and expression of the human cyclin D gene in esophageal cancer.
    Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB
    Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
    Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
    Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
    Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
    Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
    Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
    Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
    Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
    Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors.
    Hung WC; Chai CY; Huang JS; Chuang LY
    Hum Pathol; 1996 Dec; 27(12):1324-8. PubMed ID: 8958306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.
    Dongsong N; Zhou JY
    Mol Biol Rep; 2010 Oct; 37(7):3473-80. PubMed ID: 19967453
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
    Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
    J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.
    Dickson C; Fantl V; Gillett C; Brookes S; Bartek J; Smith R; Fisher C; Barnes D; Peters G
    Cancer Lett; 1995 Mar; 90(1):43-50. PubMed ID: 7720042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma.
    Gramlich TL; Fritsch CR; Maurer D; Eberle M; Gansler TS
    Diagn Mol Pathol; 1994 Dec; 3(4):255-9. PubMed ID: 7866635
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chromosome 11q13 markers and D-type cyclins in breast cancer.
    Peters G; Fantl V; Smith R; Brookes S; Dickson C
    Breast Cancer Res Treat; 1995; 33(2):125-35. PubMed ID: 7749140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Redundant cyclin overexpression and gene amplification in breast cancer cells.
    Keyomarsi K; Pardee AB
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1112-6. PubMed ID: 8430082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.